Hemispherx Biopharma (HEB) Doubles Q1 Loss to 2c/Share
Tweet Send to a FriendGet Alerts HEB Hot Sheet
Trade HEB Now!
Hemispherx Biopharma, Inc. (NYSE: HEB) reported Q1 EPS of ($0.02), versus ($0.01) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Dycom Industries, Inc. (DY) Tops Q3 EPS by 4c, Guidance Tops Views
- Analog Devices, Inc. (ADI) Reports In-Line Q2 EPS, Guidance Light
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
